Microsoft has patched the Windows Notepad remote code execution vulnerability CVE-2026-20841, warning users to install ...

A Plymouth company that makes iris-scanning software has joined the ranks of technology firms helping federal immigration authorities assemble a vast surveillance apparatus to identify targets for ...

ScanSource, Inc. (NASDAQ: SCSC), a leading technology distributor uniquely positioned to address complex, converging technologies, has been named to the Fortune World’s Most Admired Companies 2026 ...

Cybersecurity researchers have disclosed details of a security flaw that leverages indirect prompt injection targeting Google Gemini as a way to bypass authorization guardrails and use Google Calendar ...

Google has toyed with personalized answers in Gemini, but that was just a hint of what was to come. Today, the company is announcing extensive “personal intelligence” in Gemini that allows the chatbot ...

On Monday, Anthropic announced a new tool called Cowork, designed as a more accessible version of Claude Code. Built into the Claude Desktop app, the new tool lets users designate a specific folder ...

Anthropic’s agentic tool Claude Code has been an enormous hit with some software developers and hobbyists, and now the company is bringing that modality to more general office work with a new feature ...

Wegovy’s oral version of its injectable weight-loss drug is seeing tremendous interest, Novo Nordisk executive Dave Moore told FOX Business on Friday. Wegovy’s once-daily pill, an oral spinoff of its ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug injected directly into the tumor is absorbed by macrophages, prompting them ...

The technology allows you to forget about ever having to recharge the lock. The technology allows you to forget about ever having to recharge the lock. is a reviews editor who manages how-tos and ...

Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...